Cosmos Health Inc. (NASDAQ:COSM) Short Interest Update

Cosmos Health Inc. (NASDAQ:COSM) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 189,700 shares, a decline of 53.3% from the February 29th total of 406,200 shares. Approximately 1.3% of the company’s shares are sold short. Based on an average trading volume of 306,100 shares, the short-interest ratio is currently 0.6 days.

Cosmos Health Price Performance

Cosmos Health stock remained flat at $0.71 during trading on Thursday. 175,417 shares of the company were exchanged, compared to its average volume of 301,587. The business’s 50-day simple moving average is $0.84 and its 200-day simple moving average is $1.09. The company has a current ratio of 2.06, a quick ratio of 1.79 and a debt-to-equity ratio of 0.08. Cosmos Health has a 12-month low of $0.61 and a 12-month high of $4.05.

Analyst Upgrades and Downgrades

Separately, Taglich Brothers restated a “speculative buy” rating on shares of Cosmos Health in a report on Tuesday, February 20th.

Insider Buying and Selling at Cosmos Health

In other Cosmos Health news, CEO Grigorios Siokas purchased 60,000 shares of the business’s stock in a transaction on Friday, February 16th. The stock was bought at an average cost of $0.83 per share, for a total transaction of $49,800.00. Following the acquisition, the chief executive officer now owns 1,394,597 shares of the company’s stock, valued at approximately $1,157,515.51. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 18.74% of the stock is currently owned by insiders.

Institutional Trading of Cosmos Health

A number of institutional investors have recently added to or reduced their stakes in COSM. Virtu Financial LLC boosted its position in Cosmos Health by 444.0% in the 2nd quarter. Virtu Financial LLC now owns 87,969 shares of the company’s stock valued at $33,000 after buying an additional 71,799 shares during the last quarter. Jane Street Group LLC purchased a new position in Cosmos Health in the 4th quarter valued at about $46,000. CIBC Asset Management Inc purchased a new position in Cosmos Health in the 1st quarter valued at about $50,000. State Street Corp bought a new position in shares of Cosmos Health during the first quarter worth about $76,000. Finally, Vanguard Group Inc. bought a new position in shares of Cosmos Health during the third quarter worth about $212,000. 12.61% of the stock is owned by hedge funds and other institutional investors.

Cosmos Health Company Profile

Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.